Virginia Economic Review
This issue of Virginia Economic Review explores the life sciences industry in Virginia, including public and private research and development, medical laboratories, pharmaceutical and equipment manufacturing, and distribution of healthcare products. Industry highlights include several clusters of industry companies that have grown around the Commonwealth’s top-notch universities, including one partnership in Richmond and Petersburg with the potential to remake pharmaceutical supply chains in the United States. Article highlights include:
- A Supply Chain Reaction: Securing the Nation’s Essential Medicine Supply
- Life Sciences Clusters in Virginia: Innovation and Synergy Drive Growth
- Virginia Accelerators, Funds Help Make Research Breakthroughs Reality
- GlaxoSmithKline Hits the Ground Running in Richmond
- Positioned to Thrive: Embody Sets Stage for International Growth
Past Issues
Fourth Quarter 2021
This issue explores eight innovation-driven industries with transformative potential in the United States.
Third Quarter 2021
This issue details the cybersecurity industry, including Virginia’s leading position in cybersecurity talent development and the industry in general.
Second Quarter 2021
This issue explores the economic value that international trade brings to companies and consumers and details Virginia’s plan to boost exports by 50% over the next 10–15 years.
Podcasts
Helping Life Sciences Companies Succeed in Virginia: A Conversation With John Newby
March 30, 2022
CEO, Virginia Bio
Nurturing Innovation in the Life Sciences: A Conversation With Chandra Briggman
March 30, 2022
President and CEO, Activation Capital
